Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ascorbic acid–dehydroascorbic acid redox couple refers to the antioxidant mechanism where ascorbic acid (vitamin C) donates electrons to reduce oxidants, converting into its oxidized form, dehydroascorbic acid (DHA). DHA can be recycled back to ascorbic acid enzymatically (using glutathione-dependent dehydroascorbate reductase) or non-enzymatically to maintain antioxidant capacity and redox balance in cells. This process prevents cellular oxidative damage and can modulate multiple physiological and pathological processes, including inflammation, neurodegeneration, and cancer [1][2][3][7]. However, the entry itself is not a discrete drug target, receptor, enzyme, or transporter, but a chemical process involving redox-active small molecules.
Hydrogen atom/electron donation (antioxidant), Recycling by glutathione-dependent dehydroascorbate reductase, Protection of cells from oxidative damage
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ascorbic acid–dehydroascorbic acid redox couple.